Inventor
NADLER LEE M
US30 patents
⚠️ This page may combine multiple inventors who share the name “NADLER LEE M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
19 patentsUS5942607AAug 24, 1999
B7-2: a CTLA4/CD28 ligand
DANA FARBER CANCER INST INC106 citations98
US5861310AJan 19, 1999
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
DANA FARBER CANCER INST INC97 citations98
US6149905ANov 21, 2000
Tumor cells with increased immunogenicity and uses therefor
DANA FARBER CANCER INST INC32 citations95
US6130316AOct 10, 2000
Fusion proteins of novel CTLA4/CD28 ligands and uses therefore
DANA FARBER CANCER INST INC64 citations95
US6824779B1Nov 30, 2004
Methods for inhibiting the interaction of B7-2 with its natural ligand
DANA FARBER CANCER INST INC20 citations93
US6084067AJul 4, 2000
CTLA4/CD28 ligands and uses therefor
DANA FARBER CANCER INST INC31 citations93
US7619078B2Nov 17, 2009
Nucleic acid molecules encoding B7-1
DANA FARBER CANCER INST INC17 citations92
US6451305B1Sep 17, 2002
Methods for stimulating T cell responses to tumor cells expressing LFA-3 and a CD28 or CTLA4 ligand
DANA FARBER CANCER INST INC23 citations92
US7195758B2Mar 27, 2007
Methods of inducing a T cell mediated immune response by administering antigen presenting B cells
DANA FARBER CANCER INST INC21 citations91
US6465251B1Oct 15, 2002
Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin
DANA FARBER CANCER INST INC23 citations91
US7700102B2Apr 20, 2010
Nucleic acids encoding CD100 molecules
DANA FARBER CANCER INST INC23 citations90
US6653444B1Nov 25, 2003
Polypeptides comprising a B7 extracellular domain
DANA FARBER CANCER INST INC15 citations90
US6576754B2Jun 10, 2003
CD100 antigen and uses therefor
DANA FARBER CANCER INST INC31 citations90
US6071716AJun 6, 2000
DNA encoding, B7, a new member of the IG superfamily with unique expression on activated and neoplastic B cells
DANA FARBER CANCER INST INC34 citations90
US6576236B1Jun 10, 2003
Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain
DANA FARBER CANCER INST INC7 citations72
US7592007B2Sep 22, 2009
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies
DANA FARBER CANCER INST INC2 citations61
US7851591B1Dec 14, 2010
Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERT
DANA FARBER CANCER INST INC3 citations60
US8026224B2Sep 27, 2011
Tumor cells with increased immunogenicity and uses therfor
DANA FARBER CANCER INST INC1 citations59
US7955845B2Jun 7, 2011
Modified antigen-presenting cells
DANA FARBER CANCER INST INC0 citations49